Drug innovation will spur Pfizer’s dividend

PFIZER INC. $42 (New York symbol PFE; Income Portfolio, Manufacturing & Industry sector; Shares outstanding: 5.8 billion; Market cap: $243.6 billion; Dividend yield: 3.4%; Dividend Sustainability Rating: Highest; www.pfizer.com) is one of the world’s leading prescription drugmakers. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia)… Read More

Spinoff plans enhance their prospects

GENERAL ELECTRIC CO. $8.98 (New York symbol GE, Manufacturing & Industry sector; Shares outstanding: 8.7 billion; Market cap: $78.1 billion; Dividend yield: 0.5%; Takeover Target Rating: Medium; www.ge.com) recently announced a major restructuring that will narrow its focus to three main businesses: aviation operations (jet engines and aircraft… Read More

Dividend Advisor Hotline – Friday, January 4, 2019

PFIZER INC., $43.00, New York symbol PFE, is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia) and Enbrel (rheumatoid arthritis).

Starting with the March 2019 payment, Pfizer will increase its quarterly dividend by 5.9%,… Read More

These upcoming spinoffs show promise

DANAHER CORP. $101 (New York symbol DHR; Manufacturing & Industry sector; Shares outstanding: 696.6 million; Market cap: $70.4 billion; Dividend yield: 0.6%; Takeover Target Rating: Medium; www.danaher.com) makes precision-testing equipment and tools. Its major customers include medical research labs, dentists and municipal water utilities. Its brands include Beckman… Read More

Spinoff Spotlight

GLAXOSMITHKLINE PLC (ADR) $42 (New York symbol GSK; Manufacturing & Industry sector; ADRs outstanding: 2.5 billion; Market cap: $105.0 billion; Dividend yield: 3.8%; Takeover Target Rating: Low; www.gsk.com) is a U.K.-based global health-care company that develops, makes and sells products in three main markets: pharmaceuticals, vaccines and consumer… Read More